Background: Minimally invasive pancreatic pancreatoduodenectomy (MIPD) is increasingly adopted worldwide and its potential advantages include reduced hospital stay and decrease pain. However, evidence supporting the role of MIPD for tumours requiring vascular reconstruction remains limited and requires further evaluation. This study aims to investigate the safety and efficacy of MIPD with vascular resection (MIPDV) by performing a 1:1 propensity-score matched (PSM) comparison with open pancreatoduodenectomy with vascular resection (OPDV) based on a single surgeon's experience.
Methods: This is a retrospective review of 41 patients who underwent PDV between 2011 and 2020 by a single surgeon. After PSM, the comparison was made between 13 MIPDV and 13 OPDV.
Results: Thirty-six patients underwent venous reconstruction (VR) only and 5 underwent arterial reconstruction of which 4 had concomitant VR. The types of VR included 22 wedge resections with primary repair, 8 segmental resections with primary anastomosis and 11 requiring interposition grafts. Post-operative pancreatic fistula (POPF) occurred in 3 (7.3%) patients. Major complications (>Grade 2) occurred in 16 (39%) patients, of which 7 were due to delayed gastric emptying requiring nasojejunal tube placement. There was 1 (2.4%) 30-day mortality (OPDV). Of the 13 MIPDV, there were 3 (23.1%) open conversions. PSM comparison demonstrated that MIPDV was associated with longer median operative time (720 min vs. 485 min (P = 0.018). There was no statistically significant difference in other key perioperative outcomes such as intra-operative blood loss, overall morbidity, major morbidity rate, POPF and length of stay.
Conclusion: Our initial experience with the adoption MIPDV has demonstrated it to be safe with comparable outcomes to OPDV despite the longer operation time.
J Gastrointest Cancer. 2017 Jun;48(2):129-134
[PMID:
28326457]
Ann Surg. 2018 Nov;268(5):731-739
[PMID:
30138162]
HPB (Oxford). 2017 Mar;19(3):171-177
[PMID:
28189345]
J Minim Access Surg. 2015 Jul-Sep;11(3):167-71
[PMID:
26195873]
Int J Med Robot. 2020 Aug;16(4):e2113
[PMID:
32304167]
Lancet Gastroenterol Hepatol. 2021 Jun;6(6):438-447
[PMID:
33915091]
Surg Endosc. 2017 Mar;31(3):1488-1495
[PMID:
27444832]
Lancet Gastroenterol Hepatol. 2019 Mar;4(3):199-207
[PMID:
30685489]
Surg Endosc. 2018 Nov;32(11):4658-4665
[PMID:
29967997]
Ann Surg. 2019 Jan;269(1):10-17
[PMID:
29099399]
Ann Surg. 2013 Jan;257(1):128-32
[PMID:
22868357]
J Minim Access Surg. 2020 Oct-Dec;16(4):404-410
[PMID:
31571669]
Ann Acad Med Singap. 2020 Oct;49(10):742-748
[PMID:
33283837]
Ann Surg. 2019 Jan;269(1):2-9
[PMID:
30080726]
Surgery. 2017 Mar;161(3):584-591
[PMID:
28040257]
Ann Surg. 2016 Aug;264(2):257-67
[PMID:
26863398]
Surg Endosc. 2020 Jan;34(1):377-383
[PMID:
30963260]
Singapore Med J. 2017 Dec;58(12):708-713
[PMID:
27957584]
J Gastrointest Surg. 2015 Jan;19(1):189-94; discussion 194
[PMID:
25274069]
ANZ J Surg. 2019 Mar;89(3):206-210
[PMID:
29799169]
HPB (Oxford). 2017 Mar;19(3):234-245
[PMID:
28190709]
HPB (Oxford). 2018 Feb;20(2):155-165
[PMID:
28966031]
Ann Surg. 2004 Aug;240(2):205-13
[PMID:
15273542]
J Minim Access Surg. 2019 Jul-Sep;15(3):204-209
[PMID:
30416147]
Ann Acad Med Singap. 2020 Jun;49(6):377-383
[PMID:
32712635]
Br J Surg. 2017 Oct;104(11):1443-1450
[PMID:
28895142]
Int J Med Robot. 2017 Mar;13(1):
[PMID:
26813478]
Surgery. 2014 Jul;156(1):1-14
[PMID:
24856668]
Surgery. 1996 Dec;120(6):1051-4
[PMID:
8957494]
